Crossmark

0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05376-5

Published Online: 2021-07-03

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Raman, Sainath http://orcid.org/0000-0002-0152-9980
Schibler, Andreas

Marsney, Renate Le

Trnka, Peter

Kennedy, Melanie

Mattke, Adrian

Gibbons, Kristen

Schlapbach, Luregn J.
Funding

Funding for this research was provided by:

Children's Health Queensland Hospital and Health Service (2731024)
License Information

Text and Data Mining valid from 2021-07-03

Version of Record valid from 2021-07-03
More Information

Article History

Received: 2 April 2021

Accepted: 15 June 2021

First Online: 3 July 2021

Declarations

:

: The study protocol has been reviewed and approved by the ethics committee in Australia (Children’s Health Queensland Human Research Ethics Committee, HREC/19/QCHQ/53177). The details of the protocol amendments are included in Additional file InternalRef removed.

: Prospective informed consent will be sought from parents or carers on the consent form that has been reviewed by the HREC. A model consent form has been included as Additional file InternalRef removed.

: All authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below